Immunic | VTL - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
BioMarin Pharmaceutical USD 636.56M 39.61M 2026-03
Cipla INR 59.27B 1.71B 2026-03
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.19M 96K 2026-03
CSL USD 5.7B 2.82B 2025-12
Enanta Pharmaceuticals USD 126.59M 346.51M 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Immunic USD 23.33M 2.67M 2025-12
Insmed USD 506.24M 7.31M 2026-03
Omeros USD 59.16M 20.13M 2024-06
OraSure Technologies USD 40.35M 2.45M 2025-12
Quidel USD 1.85B 1.09B 2026-03
Ultragenyx Pharmaceutical USD 305M 16M 2026-03
United Therapeutics USD 5.9B 5.1B 2026-03
Xoma USD 22.84M 1.67M 2024-09